Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients

Clinical and Translational Oncology

Volumn 14, Issue 3, 2012, Pages 214-220

  Tu, Yanyang ^a   He, Shiming ^a   Fu, Jianfang ^b   Li, Gang ^a   Xu, Ruxiang ^c   Lu, Hongliu ^c   Deng, Jianping ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

EphB4; EphrinB2; Glioma; Immunohistochemistry; Prognosis

Indexed keywords

EPHRIN; EPHRIN B2; EPHRIN B4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BIOPSY; CANCER GRADING; CELLULAR DISTRIBUTION; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; BRAIN NEOPLASMS; DISEASE PROGRESSION; EPHRIN-B2; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPHB4; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860729590     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0786-2     Document Type: Article

References (33)

1. Rainov NG, Heidecke V (2011) Clinical development of experimental therapies for malignant glioma. Sultan Qaboos Univ Med J 11:5-28
2. Kleihues P, Sobin LH (2000) World Health Organization classi? cation of tumors. Cancer 88:2887 (Pubitemid 30417954)
3. Pasquale EB (1997) The Eph family of receptors. Curr Opin Cell Biol 9:608-615 (Pubitemid 27424916)
4. Maekawa H, Oike Y, Kanda S et al (2003) EphrinB2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler Thromb Vasc Biol 23:2008-2014 (Pubitemid 37433193)
5. Das A, Shergill U, Thakur L et al (2010) Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol 298:G908-G915
6. Xia G, Kumar SR, Masood R et al (2005) EphB4 expression and biological signi? cance in prostate cancer. Cancer Res 65:4623-4632 (Pubitemid 40740798)
7. Noren NK, Lu M, Freeman AL et al (2004) Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci USA 101:5583-5588 (Pubitemid 38481199)
8. Kullander K, Klein R (2002) Mechanisms and functions of Eph and ephrin signaling. Nat Rev Mol Cell Biol 3:475-486 (Pubitemid 34733429)
9. Fox BP, Kandpal RP (2004) Invasiveness of breast carcinoma cells and transcript pro? le: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Commun 318:882-892 (Pubitemid 38625856)
10. Tang XX, Brodeur GM, Campling BG et al (1999) Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin Cancer Res 5:455-460 (Pubitemid 29085201)
11. Tang XX, Jhao H, Robinson ME et al (2000) Implication of EPHB6, EFNB2 and EFNB3 expression in human neuroblastoma. Proc Natl Acad Sci U S A 97:10936-10941
12. Martiny-Baron G, Holzer P, Billy E et al (2010) The small molecule speci? c EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis. Angiogenesis 13: 259-267
13. Branco-Price C, Johnson RS (2010) Tumor vessels are Eph-ing complicated. Cancer Cell 17:533-534
14. Kumar SR, Scehnet JS, Ley EJ et al (2009) Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 69:3736-3745
15. Pennisi A, Ling W, Li X et al (2009) The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood 114:1803-1812
16. Héroult M, Schaffner F, Pfaff D et al (2010) EphB4 promotes site-speci? c metastatic tumor cell dissemination by interacting with endothelial cellexpressed ephrinb2. Mol Cancer Res 8:1297-1309
17. Xue C, Huang Z, Wang J et al (2009) EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results. Can J Ophthalmol 44:185-188
18. Yamanda S, Ebihara S, Asada M et al (2009) Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood 113:3631-3639
19. Alam SM, Fujimoto J, Jahan I et al (2007) Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. Ann Oncol 18:485-490 (Pubitemid 46359627)
20. Alam SM, Fujimoto J, Jahan I et al (2009) Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol 114:84-88
21. McCarty KS Jr, Miller LS, Cox EB et al (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716-721 (Pubitemid 16237466)
22. Catt SL, Anderson JL, Critchley GR (2011) Patients' and staff's experiences of multidisciplinary follow-up for high-grade glioma after radical radiotherapy. Psychol Health Med 16:357-365
23. Walbert T, Mikkelsen T (2011) Recurrent highgrade glioma: a diagnostic and therapeutic challenge. Expert Rev Neurother 11:509-518
24. Batlle E, Bacani J, Begthel H et al (2005) Ephb receptor activity suppresses colorectal cancer progression. Nature 435:1126-1130 (Pubitemid 40910522)
25. Wu D, Suo Z, Kristensen GB et al (2004) Prognostic value of epha2 and ephrina-1 in squamous cell cervical carcinoma. Gynecol Oncol 94:312-319 (Pubitemid 39024532)
26. Wu Q, Suo Z, Risberg B et al (2004) Expression of ephb2 and ephb4 in breast carcinoma. Pathol Oncol Res 10:26-33 (Pubitemid 38506609)
27. Xia G, Kumar SR, Stein JP et al (2006) EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 25:769-780 (Pubitemid 43214703)
28. Masood R, Kumar SR, Sinha UK et al (2006) EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer 119:1236-1248 (Pubitemid 44258795)
29. Kumar SR, Singh J, Xia G et al (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169:279-293
30. Yavrouian EJ, Sinha UK, Rice DH et al (2008) The signi? cance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 134:985-991
31. Ozgür E, Heidenreich A, Dagtekin O et al (2011) Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. Urol Oncol 29:78-84
32. Krasnoperov V, Kumar SR, Ley E et al (2010) Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol 176:2029-2038
33. Erber R, Eichelsbacher U, Powajbo V et al (2006) EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25:628-641 (Pubitemid 43237669)